Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.56%) to 10321.09, DAX (0.19%) to 24083.53, CAC40 (0.19%) to 8141.92, STOXX 600 (0.30%) to 608.84

Apr 27 ,2026

  • Synopsis:

    • European indices ended mostly lower as uncertainty surrounding US-Iran negotiations persists. Tech, energy, telcos and travel/leisure among the main laggards, while banks, media and utilities held up better. Follows last week's downbeat performance, which saw European equities snap a five-week winning streak.

    • Main focus on central bank policy updates from ECB and BoE on Thursday. While no change anticipated, attention on policy communication and rate guidance amid rising risk of stagflation. In other news, UK political backdrop turning more uncertain amid weekend press reports on possible push to remove PM Starmer, who faces a Tuesday vote on a possible referral to the Commons Privileges Committee over the Peter Mandelson appointment. Former deputy PM Rayner has increasingly been tipped in the press as a favorite.

    • On the macro calendar, German GfK consumer confidence data missed expectations (33.3) vs consensus (29.5) and prior revised (28.1) from (28.0). In the UK, the latest April CBI distributive trades survey showed a deterioration in retail conditions (67) versus consensus (48) and the prior reading (52).

    • In M&A news, Apollo funds have acquired Forvia (FRVIA.FP) interiors unit in a deal based on a EV of €1.82B ($2.13B) whilst - in the Nordics - a consortium including Triton has offered to acquire Cint Group (CINT.SS) for SEK5.60/sh in cash. On a busy UK front, Intertek Group (ITRK.LN) rejected a previously disclosed acquisition offer from EQT, E.ON (EOAN.GR) is looking at buying Ovo Energy and local press wrote that Whitbread (WTB.LN) is likely to sell and lease back 20% of its freehold Premier Inn hotels; in France, holder Mundys exercised its right to acquire up to 25.0% of share capital and 29.9% of voting rights of Getlink (GET.FP). On the reporting front, Nordex (NDX1.GR), Galp Energia (GALP.PL), Exosens (EXENS.FP) and Mutares SE & Co KGaA (MUX.GR) updated investors before the open.

    • Looking ahead to tomorrow's EU econ-calendar, key releases will include, amongst others, UK Apr shop price inflation - BRC and Italy Mar PPI.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Banks +0.44%, Media +0.33%, Utilities +0.16%, Financial Svcs +0.25%, Ind Goods & Svcs +0.11%, Health Care +0.12%, Construct & Mtls (0.12%), Chemicals (0.20%), Autos & Parts (0.10%)

      • Underperformers:

        • Technology (1.34%), Oil & Gas (1.12%), Telecom (0.99%), Travel & Leisure (1.09%), Basic Resources (0.91%), Insurance (0.61%), Food & Beverage (0.52%), Retail (0.54%), Real Estate (0.45%), Persnl & HHold Goods (0.49%)

    • Macro:

      • Central banks:

        • ECB to hold the line at this week's meeting -- Investinglive, citing Goldman Sachs

        • Bank of England to Stress Test Longer Energy Shock, Hold Interest Rates on Iran War -- Bloomberg

      • EU:

        • EU's von der Leyen statement at the meeting of the board of the CDU/CSU group in the German Bundestag -- EC

        • Italy calls for EU to treat energy spending like defence in bloc's budget rules -- Reuters

      • UK:

        • UK's Starmer to Face Vote on Probe Into Mandelson Claims -- Bloomberg

        • The UK's 100% debt-to-GDP ratio was a statistical dream -- FT

      • Germany:

        • Most Germans support welfare constraints on immigrants, poll finds -- Times

        • Merz's Economic Headache Shows No Signs of Abating -- Bloomberg

      • Sweden:

        • The Government presents a new national infrastructure plan -- Regeringen

      • Turkey:

    • Company news:

      • Notable Gainers

        • +21.0% OSE.FP (OSE Immunotherapeutics €3.70, +0.63) -- FDA ODD to pegrizeprument (VEL‑101)

        • +11.4% HUM.SS (Humana AB SEK47.40, +4.95) -- SEB upgrade

        • +9.6% CRNA.NO (Circio Holding NOK9.65, +0.83) -- cancels previously planned subsequent offering of shares

        • +8.0% SGF.IM (Sogefi €2.23, +0.16) -- Q1 earnings

        • +6.0% HEAD.LN (Headlam Group £0.30, +0.02) -- holder First Seagull's request to convene a general meeting

        • +5.9% KIN.BB (Kinepolis Group €29.65, +1.70) -- Estimated weekend box office revenues in US, Canada $150.8M, +2.8% y/y - Box Office Mojo

        • +5.8% HLG.GR (Highlight Communications €0.97, +0.05) -- Estimated weekend box office revenues in US, Canada $150.8M, +2.8% y/y - Box Office Mojo

        • +5.7% NDX1.GR (Nordex €49.74, +2.58) -- Q1 earnings

        • +5.5% EYE.LN (Eagle Eye Solutions Group £3.93, +0.21) -- to host Capital Markets Day on 21-May

        • +5.1% ANP.LN (Anpario £5.00, +0.24) -- £3.0M share buyback

        • +4.2% CLI.LN (CLS Holdings £0.50, +0.02) -- sale of The Brix for €60.0M

        • +4.0% ORSTED.DC (Ørsted DKK165.30, +6.50) -- Goldman Sachs upgrade

        • +3.4% CO.FP (Casino Guichard-Perrachon €0.15, +0.01) -- updates on the sale of its stake in Companhia Brasileira de Distribuição (GPA)

        • +2.9% ARCH.NO (Archer NOK29.05, +0.80) -- contract

        • +2.8% CANTA.SS (Cantargia SEK3.88, +0.10) -- nadunolimab in MDS and AML study results

        • +2.4% CBK.GR (Commerzbank €34.63, +0.81) -- BofA upgrade

        • +1.9% TOM.NO (Tomra Systems NOK92.30, +1.75) -- Sparebank 1 Markets upgrade

      • Notable Decliners

        • -11.0% BGO.LN (Bango £0.71, -0.09) -- FY earnings

        • -3.6% VBG.B.SS (VBG Group SEK345.00, -12.50) -- Q1 earnings

        • -3.5% MYCR.SS (Mycronic SEK296.60, -10.60) -- Nordea downgrade; SEB downgrade; ABG Sundal Collier downgrade

        • -3.3% SBRY.LN (J Sainsbury £3.34, -0.12) -- Goldman Sachs downgrade

        • -3.0% NCAB.SS (NCAB Group SEK71.40, -2.20) -- Pareto downgrade

        • -2.3% COR.PL (Corticeira Amorim SGPS €6.38, -0.15) -- Bestinver Securities downgrade

        • -1.4% APETIT.FH (Apetit €13.75, -0.20) -- Inderes downgrade

        • -0.2% SZU.GR (Suedzucker €0.00, -0.02) -- prelim. FY earnings

    • EU companies reporting tomorrow:

      • Earnings:

        • Austria: STRABAG (STR.AV)

        • Benelux: PostNL (PNL.NA)

        • Denmark: Alm. Brand (ALMB.DC), Embla Medical hf (EMBLA.DC), Tivoli (TIV.DC)

        • Finland: Wartsila (WRT1V.FH), Valmet (VALMT.FH), Yit (YIT.FH), Alandsbanken (ALBBV.FH), Revenio Group (REG1V.FH), eQ (EQV1V.FH), Lindex Group (LINDEX.FH), Enento Group (ENENTO.FH), Pihlajalinna (PIHLIS.FH), Tecnotree (TEM1V.FH)

        • France: Airbus (AIR.FP), Nexans (NEX.FP), Bic (BB.FP), M6-Metropole (MMT.FP), Lectra (LSS.FP)

        • Germany: Stratec (SBS.GR), Hawesko Holding (HAW.GR)

        • Norway: Telenor (TEL.NO), Nordic Semiconductor (NOD.NO), Atea (ATEA.NO), Klaveness Combination Carriers (KCC.NO), Zalaris (ZAL.NO)

        • Other: Icelandair Group (ICEAIR.IR)

        • Sweden: Atlas Copco (ATCO.A.SS), Assa Abloy (ASSA.B.SS), Boliden (BOL.SS), SSAB (SSAB.A.SS), Swedish Orphan Biovitrum (SOBI.SS), Securitas (SECU.B.SS), AarhusKarlshamn (AAK.SS), Sweco (SWEC.B.SS), Holmen (HOLM.B.SS), Munters Group (MTRS.SS), AddLife (ALIF.B.SS), Hacksaw (HACK.SS), Billerud (BILL.SS), Electrolux Professional (EPRO.B.SS), AFRY (AFRY.SS), Alimak Group (ALIG.SS), Hemnet Group (HEM.SS), Addnode Group (ANOD.B.SS), Inwido (INWI.SS), Sdiptech (SDIP.B.SS), Storytel (STORY.B.SS), RVRC Holding (RVRC.SS), Eastnine (EAST.SS), Ependion (EPEN.SS), Bonava (BONAV.B.SS), Nelly Group (NELLY.SS), Solid Försäkring (SFAB.SS), CTT Systems (CTT.SS), Genovis (GENO.SS), Ework Group (EWRK.SS), Micro Systemation (MSAB.B.SS), Softronic (SOF.B.SS), Alcadon Group (ALCA.SS), ProfilGruppen (PROF.B.SS), Orexo (ORX.SS), Logistea (LOGI.A.SS), Dedicare (DEDI.SS), Lammhults Design Group (LAMM.B.SS), Boule Diagnostics (BOUL.SS)

        • Switzerland: Novartis (NOVN.SW), Idorsia (IDIA.SW), Santhera Pharmaceuticals Holding (SANN.SW), Xlife Sciences (XLS.SW)

        • UK: BP (BP.LN), Barclays (BARC.LN), Georgia Capital (CGEO.LN), Card Factory (CARD.LN), Tullow Oil (TLW.LN), Eleco (ELCO.LN), Tracsis (TRCS.LN), Likewise Group (LIKE.LN)

      • Trading Update:

        • Benelux: Coca-Cola Europacific Partners (CCEP.NA), PostNL (PNL.NA)

        • DACHs: SIG Combibloc Group (SIGN.SW), Bucher Industries (BUCN.SW)

        • France: Air Liquide (AI.FP), Aeroport de Paris (ADP.FP), Teleperformance (TEP.FP), Altarea (ALTA.FP), Alten (ATE.FP), Vetoquinol (VETO.FP), Manitou BF (MTU.FP), Worldline (WLN.FP), Mersen (MRN.FP), SMCP (SMCP.FP), Haulotte Group (PIG.FP), Verimatrix (VMX.FP)

        • Nordics: SSH Communications Security (SSH1V.FH)

        • Southern Europe: Puig Brands (PUIG.SM)

        • UK: Anglo American (AAL.LN), Howden Joinery Group (HWDN.LN), Taylor Wimpey (TW.LN), WPP Group (WPP.LN)

  • Data:

    • Economics:

      • UK Apr CBI Distributive Trades (67) vs consensus (48) and prior (52)

      • Germany May GfK Consumer Confidence (33.3) vs consensus (29.5) and prior revised (28.1) from (28.0)

    • Markets:

      • WTI Crude (26-Jun): +$2.59 or +2.74% to $96.99

      • €-$ +0.0033 or +0.28% to 1.1734

      • £-$ +0.0042 or +0.31% to 1.3549

      • €-£ (0.0003) to 0.8660

      • S&P 500 (0.17%)

      • Performance year-to-date:

        • FTSE 100: +3.92%

        • DAX: (1.66%)

        • CAC: (0.09%)

        • MIB: +6.07%

        • Stoxx 600: +2.81%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.